TP53 and neoplasm: Contrary to published results on increased sensitivity of mutant p53 to statins [31], we observed consistent but mild and statistically insignificant increase in sensitivity of Pten∆f:p53∆f tumor cells to HMG-CoA inhibitors relative to Pten∆f:p53R270H tumor cells.